[1] Campbell BR, Sanders CB, Netterville JL, et al.Early onset oral tongue squamous cell carcinoma: associated factors and patient outcomes[J]. Head Neck, 2019, 41(6): 1952-1960. [2] Yuan S, Lin LS, Gan RH, et al.Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma[J]. BMC Cancer, 2020, 20(1):33-44. [3] Jafarian AH, Kooshki Forooshani M, Reisi H, et al.Matrix metalloproteinase-9 (MMP-9) expression in non-small cell lung carcinoma and its association with clinicopathologic factors[J]. Iran J Pathol, 2020, 15(4): 326-333. [4] Ashraf TS, Obaid A, Saeed TM, et al.Formal model of the interplay between TGFβ1 and MMP-9 and their dynamics in hepatocellular carcinoma[J]. Math Biosci Eng, 2019, 16(5): 3285-3310. [5] Väyrynen O, Äström P, Nyberg P, et al.Matrix metalloproteinase 9 inhibits the motility of highly aggressive HSC-3 oral squamous cell carcinoma cells[J]. Exp Cell Res, 2019, 376(1): 18-26. [6] Ohta K, Yoshimura H.Squamous cell carcinoma of the dorsal tongue[J]. CMAJ, 2019, 191(47): E1310-E1310. [7] Hararah MK, Stokes WA, Oweida A, et al.Epidemiology and treatment trends for primary tracheal squamous cell carcinoma[J]. Laryngoscope, 2020, 130(2): 405-412. [8] Zhu L, Wang Y, Li R, et al.Surgical treatment of early tongue squamous cell carcinoma and patient survival[J]. Oncol Lett, 2019, 17(6): 5681-5685. [9] Huang W, Zhou R, Mao L, et al.Esophageal cancer related gene-4 inhibits the migration and proliferation of oral squamous cell carcinoma through BC200 lncRNA/MMP-9 and -13 signaling pathway[J]. Cell Signal, 2019, 62: 109327. [10] Karmakar D, Maity J, Mondal P, et al.E2F5 promotes prostate cancer cell migration and invasion through regulation of TFPI2, MMP-2 and MMP-9[J]. Carcinogenesis, 2020, 41(12): 1767-1780. [11] Yuan J, Xu XJ, Lin Y, et al.LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression[J]. Eur Rev Med Pharmacol Sci, 2019, 23(1): 198-206. [12] Magrin GL, Di Summa F, Strauss FJ, et al.Butyrate decreases ICAM-1 expression in human oral squamous cell carcinoma cells[J]. Int J Mol Sci, 2020, 21(5): 1679-1693. [13] Halpern AL, Kohtz PD, Rove JY, et al.Inhibition of secretory phospholipase A2 Ⅱa attenuates prostaglandin E2-induced invasiveness in lung adenocarcinoma[J]. Mol Cell Biochem, 2019, 456(1-2): 145-156. [14] Yuan L, Zhou M, Wasan HS, et al.Jiedu sangen decoction inhibits the invasion and metastasis of colorectal cancer cells by regulating EMT through the hippo signaling pathway[J]. Evid Based Complement Alternat Med, 2019: 1431726. [15] Song XH, Chen XZ, Chen XL, et al.Peritoneal metastatic cancer stem cells of gastric cancer with partial mesenchymal-epithelial transition and enhanced invasiveness in an intraperitoneal transplantation model[J]. Gastroenterol Res Pract, 2020: 3256538. [16] Che X, Lu R, Fu Z, et al.Therapeutic effects of tyroserleutide on lung metastasis of human hepatocellular carcinoma SK-HEP-1 and its mechanism affecting ICAM-1 and MMP-2 and -9[J]. Drug Des Devel Ther, 2018, 12: 3357-3368. [17] 程琦, 徐松涛, 饶淑梅, 等. 托芬那酸通过下调LOXL2表达抑制人胃癌SGC-7901细胞侵袭[J]. 中国免疫学杂志, 2020, 36(21): 2624-2634. [18] Xie D, Zheng GZ, Xie P, et al.Antitumor activity of resveratrol against human osteosarcoma cells: a key role of Cx43 and Wnt/β-catenin signaling pathway[J]. Oncotarget, 2017, 8(67): 111419-111432. |